Find uplifting stories about heroes, innovations, and solutions
6975 results for "** lupus treatment"
Researchers at UT San Antonio have identified the first potential probiotic treatment for lupus, offering new hope for millions living with this chronic autoimmune disease. This groundbreaking discovery could transform how doctors approach lupus care.
Doctors in Buffalo are reprogramming patients' immune cells to fight autoimmune diseases the same way they fight cancer. The one-time treatment could replace lifelong medications for millions living with lupus, MS, and rheumatoid arthritis.
Millions living with a painful, scarring skin disease may soon have hope for the first treatment designed specifically for their condition. The FDA just granted breakthrough status to a new drug that could change lives for people with cutaneous lupus.
A new drug called EG501 significantly improved cognitive function in lupus patients during a 12-week trial, offering hope for the 80% who struggle with debilitating brain fog. Vanderbilt researchers discovered the biological cause and successfully targeted it with treatment.
Scientists at the University of Oklahoma just received $1.7 million to study a protein that may finally explain why lupus develops and how to treat it without crushing the entire immune system. The research could lead to the first major lupus treatment breakthrough in 60 years.
Scientists have discovered that a cancer treatment called CAR T-cell therapy can stop autoimmune diseases like lupus and multiple sclerosis without the dangerous side effects. Hundreds of patients are already experiencing remarkable recoveries, and the first treatments could be approved next year.
A groundbreaking treatment that reboots the immune system has put lupus patients into remission for over 18 months in early UK trials. Katie Tinkler, sick for 30 years, is now medication-free and skiing again.
A revolutionary therapy originally designed to fight blood cancer is helping people with severe lupus and other autoimmune diseases achieve remission. Early results show the treatment can reprogram the immune system instead of just suppressing it.
A groundbreaking combination treatment for lupus nephritis just won approval in England, offering 12,000 people with kidney damage a real shot at restored health. The therapy works twice as well as current options at bringing kidney function back to normal.
Researchers discovered that a specific gut bacterium depleted in lupus patients can significantly reduce disease symptoms when restored. The breakthrough could lead to safer treatments for 1.5 million Americans living with the chronic autoimmune disease.
A breakthrough treatment called EG501 has successfully cleared brain fog in lupus patients during a 12-week trial, offering hope for the 80% of people with the disease who struggle with memory and focus. Researchers finally identified the biological cause and found a way to fix it.
Five lupus patients in the UK achieved remission using CAR T-cell therapy, a cancer treatment now showing promise for autoimmune diseases. One woman celebrated by skiing the Alps and dancing at her daughter's wedding for the first time in years.
People with lupus can now treat themselves at home with an FDA-approved autoinjector pen, replacing hospital visits for IV infusions. The new option makes a proven treatment more accessible for millions living with the serious autoimmune disease.
A groundbreaking study shows that hydroxychloroquine, typically used to treat lupus symptoms, dramatically lowers the risk of serious heart problems in patients with discoid lupus. The findings could change how doctors treat this condition that predominantly affects young Black women. #
A new treatment from Biogen is showing encouraging results for people living with lupus, particularly helping clear painful skin symptoms. The mid-stage clinical trial marks a hopeful step forward for the millions worldwide affected by this autoimmune disease.
A therapy that fights cancer is being adapted to treat lupus, MS, and other autoimmune diseases affecting nearly one in 10 Americans. Researchers at Roswell Park aim to replace lifelong medications with a single infusion.
A common lupus medication may protect patients with a skin form of the disease from heart complications and diabetes. Johns Hopkins researchers found the drug reduced cardiovascular risks significantly over five years.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
A groundbreaking UK trial used CAR T-cell therapy, originally designed for cancer, to send five lupus patients into remission within three months. One patient who couldn't walk without pain just two years ago recently went Alpine skiing for the first time.
Showing 20 of 6975